Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025
Q1 FY21 results · Apr–Jun 2020
Advanced Enzyme Technologies reported revenue from operations of ₹110.50 crore (up 0.1% from Q1 FY20) and net profit of ₹34.80 crore (up 2.5% from Q1 FY20) for Q1 FY21 (Apr–Jun 2020), on a consolidated basis.
| Item | Q1 FY21 | Q1 FY20 | YoY | Q4 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 110.50 | 110.34 | +0.1% | 110.26 | +0.2% |
| Other income | 5.23 | 1.06 | +393.8% | 1.84 | +184.0% |
| Total income | 115.73 | 111.40 | +3.9% | 112.11 | +3.2% |
| Profit before tax | 49.78 | 47.47 | +4.9% | 43.20 | +15.2% |
| Net profit for the period | 34.80 | 33.97 | +2.5% | 32.68 | +6.5% |
| Attributable to shareholders of the company | 34.25 | 33.40 | +2.5% | 31.33 | +9.3% |
| EPS, basic (₹) | 3.07 | 2.99 | +2.7% | 2.81 | +9.3% |
| Net margin (%) | 31.5 | 30.8 | 29.6 |
| Item | Q1 FY21 | Q1 FY20 | YoY | Q4 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 61.41 | 58.51 | +4.9% | 68.42 | −10.3% |
| Other income | 0.73 | 1.64 | −55.5% | 1.29 | −43.4% |
| Total income | 62.13 | 60.15 | +3.3% | 69.71 | −10.9% |
| Profit before tax | 21.73 | 18.19 | +19.5% | 21.60 | +0.6% |
| Net profit for the period | 15.32 | 13.27 | +15.4% | 16.00 | −4.3% |
| EPS, basic (₹) | 1.37 | 1.19 | +15.1% | 1.43 | −4.2% |
| Net margin (%) | 25.0 | 22.7 | 23.4 |
Consolidated
- Filed with BSE
- 13 Aug 2020, 08:34 IST
- Board meeting
- 12 Aug 2020
- Period
- 01 Apr 2020 to 30 Jun 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 Aug 2020, 08:34 IST
- Board meeting
- 12 Aug 2020
- Period
- 01 Apr 2020 to 30 Jun 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE